Prime Therapeutics
The SIU Investigator at Prime Therapeutics conducts investigations into potential pharmacy, member, and prescriber fraud, waste, and abuse to protect plan integrity. The role analyzes claims data, prepares investigative findings and reports, and supports remediation, recovery, and referrals to appropriate agencies. This is a remote position focused on ensuring proper identification and escalation of suspected FWA.
Headquarters
Eagan, Minnesota, United States
Company Size
1001-5000 employees
Founded
1998
Turning barriers into breakthroughs. Questions into trust. Fears into cures. See how we're reimagining pharmacy solutions.
EmblemHealth taps Prime Therapeutics, Amazon for new pharmacy benefit collaboration
Oct 29, 2025
Prime Therapeutics expands Sempre Health partnership to rein in drug costs
Nov 2, 2025
Prime Therapeutics and Sempre Health Expand Innovative Behavior-Based Pricing Model to Advance Patient Affordability
Oct 30, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Prime Therapeutics.
A Blueprint for Action: Michigan’s Lawsuit Against Express Scripts and Prime Therapeutics Signals a Turning Point for Independent Pharmacies, Plan Sponsor, Patients, and State Enforcement
May 2, 2025